Favaloro Emmanuel J, Lippi Giuseppe
Haematology Department, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW Health Pathology, Westmead, NSW, 2145, Australia.
Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Methods Mol Biol. 2017;1646:545-559. doi: 10.1007/978-1-4939-7196-1_40.
Analytical concerns within hemostasis and thrombosis testing are continuously decreasing. This is essentially attributable to modern instrumentation, improvements in test performance and reliability, as well as the application of appropriate internal quality control and external quality assurance measures. Pre-analytical issues are also being dealt with in some newer instrumentation, which are able to detect hemolysis, icteria and lipemia, and, in some cases, other issues related to sample collection such as tube under-filling. Post-analytical issues are generally related to appropriate reporting and interpretation of test results, and these are the focus of the current overview, which provides a brief description of these events, as well as guidance for their prevention or minimization. In particular, we propose several strategies for improved post-analytical reporting of hemostasis assays and advise that this may provide the final opportunity to prevent serious clinical errors in diagnosis.
止血与血栓形成检测中的分析问题正在不断减少。这主要归因于现代仪器、检测性能和可靠性的提高,以及适当的内部质量控制和外部质量保证措施的应用。一些较新的仪器也在处理分析前问题,这些仪器能够检测溶血、黄疸和脂血,在某些情况下,还能检测与样本采集相关的其他问题,如采血管充盈不足。分析后问题通常与检测结果的适当报告和解释有关,这些是当前综述的重点,综述简要描述了这些情况,并为预防或最小化这些情况提供了指导。特别是,我们提出了几种改进止血检测分析后报告的策略,并建议这可能是防止诊断中严重临床错误的最后机会。